Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06273124 · ClinicalTrials.gov registry record · NA
Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes
A NA study, sponsored by Tandem Diabetes Care.
- Completed
- Registry status
- NA
- Development phase
- 260
- Enrollment target
NCT06273124 is a NA study that has completed, run by Tandem Diabetes Care. The registered enrollment target is 260 participants.
The verdict
NCT06273124, a NA study, has completed, sponsored by Tandem Diabetes Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 260 participants
- Enrollment target
Study Summary
The purpose of this study is to collect clinical data to support a 7-day wear of the Extended Wear Infusion Set (EWIS). Participants will be asked to: 1. Wear the EWIS for up to 7 consecutive days for 12 consecutive wear periods 2. Perform blood glucose and ketone measurements if continuous glucose meter is ≥250mg/dL for one hour
Interventions
- DEVICE SteadiSet Extended Wear Infusion Set
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2024-03-07 |
| Est. Completion | 2024-12-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06273124
The ClinicalTrials.gov registry entry for NCT06273124 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tandem Diabetes Care, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SteadiSet Extended Wear Infusion Set is the first listed.
NCT06273124 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06273124 about?
NCT06273124 is a clinical study titled "Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes". The purpose of this study is to collect clinical data to support a 7-day wear of the Extended Wear Infusion Set (EWIS). Participants will be asked to: 1. Wear the EWIS for up to 7 consecutive days for 12 consecutive wear periods 2. Perform blood glucose and ketone measurements if continuous glucos...
What is the current status of trial NCT06273124?
This trial is currently completed. It is a NA study. The enrollment target is 260 participants. The study started on 2024-03-07. Estimated completion is 2024-12-11.
What interventions are being tested in trial NCT06273124?
The interventions under investigation include: SteadiSet Extended Wear Infusion Set (DEVICE).
Who is sponsoring clinical trial NCT06273124?
This trial is sponsored by Tandem Diabetes Care, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.